Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
IntroductionThe prime-boost COVID-19 mRNA vaccination strategy has proven to be effective against severe COVID-19 disease and death. However, concerns have been raised due to decreasing neutralizing antibody levels after COVID-19 vaccination and due to the emergence of new immuno-evasive SARS-CoV-2...
Main Authors: | Milja Belik, Oona Liedes, Saimi Vara, Anu Haveri, Sakari Pöysti, Pekka Kolehmainen, Sari Maljanen, Moona Huttunen, Arttu Reinholm, Rickard Lundberg, Marika Skön, Pamela Österlund, Merit Melin, Arno Hänninen, Antti Hurme, Lauri Ivaska, Paula A. Tähtinen, Johanna Lempainen, Laura Kakkola, Pinja Jalkanen, Ilkka Julkunen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1099246/full |
Similar Items
-
Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
by: Antti Hurme, et al.
Published: (2022-04-01) -
T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency – a 22-month follow-up
by: Antti Hurme, et al.
Published: (2023-05-01) -
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination
by: Pinja Jalkanen, et al.
Published: (2022-04-01) -
Long-term COVID-19 vaccine- and Omicron infection-induced humoral and cell-mediated immunity
by: Milja Belik, et al.
Published: (2024-11-01) -
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
by: Arttu Reinholm, et al.
Published: (2024-02-01)